Cameroon vs Sao Tome and Principe: Previously treated cases tested for RR-/MDR-TB
Cameroon
100.0%
in 2024
Sao Tome and Principe
100.0%
in 2024
Cameroon rank
1st
Sao Tome and Principe rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Cameroon
- Sao Tome and Principe
How they compare
Cameroon currently reports 100.0% against 100.0% in Sao Tome and Principe, a difference of 0.0%.
The two have swapped places 4 times across 13 shared years of data; in 2012 it was Sao Tome and Principe ahead.
Cameroon ranks 1st and Sao Tome and Principe ranks 1st of 180 countries.
Cameroon has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Cameroon | Sao Tome and Principe | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 59.1% | 29.6% | 29.5% | Cameroon |
| 2020s | 97.2% | 60.0% | 37.2% | Cameroon |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Cameroon or Sao Tome and Principe?
- Cameroon, at 100.0% against 100.0% in Sao Tome and Principe as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Cameroon and Sao Tome and Principe?
- 0.0%, with Cameroon ahead.
- How many years of comparable data are there for Cameroon and Sao Tome and Principe?
- 13 years are reported by both, from 2012 to 2024.
- How do Cameroon and Sao Tome and Principe rank globally for previously treated cases tested for rr-/mdr-tb?
- Cameroon ranks 1st and Sao Tome and Principe ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.